click to open

• Vaginal micronized progesterone versus intramuscular progesterone for luteal support in women undergoing in vitro fertilization–embryo transfer

• Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate

• Unilateral versus bilateral adnexal disease in stage IIIand stage IV endometriosis does not affect pregnancy outcome after operative laparoscopy

• Reproductive outcome after IVF following hysteroscopic division of incomplete uterine septum/arcuate uterine anomaly in women with primary infertility

• Suturing versus flowering technique of Bruhat after fimbrioplasty for endometriosis-related infertility

• The prevalence of fimbrial pathology in patients with early stages of endometriosis

• Single-dose administration of an aromatase inhibitor for ovarian stimulation

• Serum human chorionic gonadotropin level after ovulation triggering is influenced by the patient’s body mass index and the number of larger follicles

• operative hysteroscopy for uterine septum

• Aromatase Inhibitors for Assisted Reproduction

• Laparoscopic management of tubal ectopic pregnancy in obese women

• High ovulatory rates with use of troglitazone in clomiphene-resistant women with polycystic ovary syndrome

• Human chorionic gonadotropin administration is associated with high pregnancy rates during ovarian stimulation and timed intercourse or intrauterine insemination

• Management of reproductive needs in cancer patients: clinical perspectives

• Prevention of bone loss and hypoestrogenic symptoms by estrogen and interrupted progesterone add-back in long-term GnRH agonist down-regulated patients with endometriosis and premenstrual syndrome

• Insulin-like 3/Relaxin-Like Factor Gene Mutations Are Associated with Cryptorchidism*

• Gestational sac aspiration: A novel alternative to Dilation and Evacuation for management of early pregnancy failure

• Pregnancy outcome after the use of an aromatase inhibitor for ovarian stimulation

• Fertility preservation and minimizing reproductive damage in cancer survivors

• Effect of cancer and cancer treatment on human reproduction

• Estradiol production during controlled ovarian hyperstimulation correlates with treatment outcome in women undergoing in vitro fertilization– embryo transfer

• Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders

• Aromatase inhibition reduces gonadotrophin dose required for controlled ovarian stimulation in women with unexplained infertility

• Aromatase Inhibitors for Endometriosis

• Endometrial thickness is related to miscarriage rate, but not to the estradiol concentration, in cycles down-regulated with gonadotropin-releasing hormone antagonist

• Human chorionic gonadotropin administration is associated with high pregnancy rates during ovarian stimulation and timed intercourse or intrauterine insemination

• Aromatase Inhibition Reduces the Dose of Gonadotropin Required for Controlled Ovarian Hyperstimulation